Competitive binding assay Immunoassay

Enzyme Immunosensors. Enzyme immunosensors are enzyme immunoassays coupled with electrochemical sensors. These sensors (qv) require multiple steps for analyte determination, and either sandwich assays or competitive binding assays maybe used. Both of these assays use antibodies for the analyte of interest attached to a membrane on the surface of an electrochemical sensor. In the sandwich assay type, the membrane-bound antibody binds the sample antigen, which in turn binds another antibody that is enzyme-labeled. This immunosensor is then placed in a solution containing the substrate for the labeling enzyme and the rate of product formation is measured electrochemically. The rate of the reaction is proportional to the amount of bound enzyme and thus to the amount of the analyte antigen. The sandwich assay can be used only with antigens capable of binding two different antibodies simultaneously (53). 

Methods based on chemiluminescent and bioluminescent labels are another area of nonisotopic immunoassays that continue to undergo active research. Most common approaches in this category are the competitive binding chemiluminescence immunoassays and the immunochemiluminometric assays. Chemiluminescence and heterogenous chemiluminescence immunoassays have been the subject of excellent reviews (91, 92). Detection in chemiluminescence immunoassays is based on either the direct monitoring of conjugated labels, such as luminol or acridinium ester, or the enzyme-mediated formation of luminescent products. Preparation of various derivatives of acridinium esters has been reported (93, 94), whereas a variety of enzyme labels including firefly or bacterial luciferase (70), horseradish peroxidase (86, 98), and alkaline phosphatase are commercially available. 

Enzyme Immunosensors. Enzyme immunosensors are enzyme immunoassays coupled with electrochemical sensors. These sensors require multiple steps for analyte determination, and either sandwich assays or competitive binding assays may be used. Both of these assays use antibodies for the analyte of interest attached to a membrane on the surface of an electrochemical sensor. 

Bovine serum albumin (BSA) and cyclic AMP (cAMP) are determined by a competitive binding enzyme immunoassay (315). With urease as label, an ammonia gas-sensing electrode is used to measure the amount of urease-labeled antigen bound to a double-antibody solid phase by continuously measuring the rate of ammonia produced from urea as substrate. The method yields accurate and sensitive assays for proteins (BSA less than 10 ng/mL) and antigens (cAMP less than 10 nM), with fairly good selectivity over cGMP, AMP, and GMP. 

Competitive Binding Assays Radioimmunoassay and Enzyme Immunoassay... 

The development of the warfarin immunoassays illustrates several points that are of value in development and use of enantioselective assays. In assays of this type, not only must enantioselectivity be considered, but also the cross-reaction with metabolites is still of importance. As in any RIA, high-specific-activity radioligand is required for the best sensitivity. The use of optically pure radioligand is a further advantage in enantioselectivity. The standard samples used for competitive binding assays must also be essentially optically pure. Otherwise, misleadingly high cross-reacrions may be observed. 

For example, several strategies have been used for immunoassay techniques with fiber-optic biosensors. In the sandwich format, the receptor is immobilized on the stu"face of the fiber waveguide and a secondary or tracer antibody (which is labelled with a fluorescent dye) is added to the solution. In the absence of the analyte, the tracer remains in solution and little fluorescence is observed. However, after addition of the analyte, a molecular sandwich is formed on the sensor smface within the evanescent excitation volume. The sandwich assay is usually more sensitive than a competitive-binding assay because the fluorescence intensity increases with analyte concentration. 

Both competitive and noncompetitive methods have been incorporated into homogeneous enzyme-labeled immunoassay kits that ultimately relate enzyme activity to analyte concentration.22 The competitive-binding assays are called enzyme-multiplied immunoassay technique (EMIT), substrate-labeled fluorescein immunoassay (SLFIA), apoenzyme reactivation immunoassay (ARIS), and cloned enzyme donor immunoassay (CEDIA), while a noncompetitive method is called enzyme inhibitory homogeneous immunoassay (EIHIA). 

Methods based on radiolabels continue to hold an important place in routine analysis and in research related to clinical testing. The main techniques included in this group are radioimmunoassy (RIA), immunoradiometric assay (IRMA), and scintillation proximity assay (SPA). Many researchers in this field use short-lived radioisotopes and chelating agents in antibody labeling.139 The most popular types of immunoassay are methods that use enzymatic labels the enzyme-linked immunosorbent assay (ELISA), the enzyme-monitored immunotest (EMIT), the competitive binding enzyme immunoassay (EIA), and the immunoenzymometric assay (IEMA). 

Molecularly imprinted sorbent assays represent one of the most typical applications of biomimetic use, where imprinted polymers are used as substitutes of natural antibodies in immunoassays. The assays usually involve competitive binding of an analyte with a certain quantity of labeled ligands, in which the labeled ligand unbound is proportional to the analyte added. Because dissociation constants of common imprinted polymers are around 10 6-10 9 M, competitive binding assays could easily be performed. In practice, many molecularly imprinted sorbent assays have been developed for biologically active compounds, including theophylline, diazepam [26], S-propranolol [27], morphine, Leu-enkephalin [28], cyclosporin A [29], yohimbine [30], methyl-a-glucoside [31], corticosteroid [32], atrazine [33, 34], and 2,4-D [35]. 

In CE, analysis by immunoassays depends on the principles that the antigen and antibody migrate differently when they are bound compared to when they are free. One of these two compounds (mostly the antigen) is labeled with a fluorescent tag. The unknown sample is mixed with labeled antigen for competitive binding assay and the mixture is separated by CE. The label in the bound fraction (or... 

In many instrumental analysis methods the instrument response is proportional to the analyte concentration over substantial concentration ranges. The simplified calculations that result encourage analysts to take significant experimental precautions to achieve such linearity. Examples of such precautions include the control of the emission line width of a hollow-cathode lamp in atomic absorption spectrometry, and the size and positioning of the sample cell to minimize inner filter artefacts in molecular fluorescence spectrometry. However, many analytical methods (e.g. immunoassays and similar competitive binding assays) produce calibration plots that are intrinsically curved. Particularly common is the situation where the calibration plot is linear (or approximately so) at low analyte concentrations, but becomes curved at higher analyte levels. When curved calibration plots are obtained we still need answers to the questions listed in Section 5.2, but those questions will pose rather more formidable statistical problems than occur in linear calibration experiments. 

In fact, most RIAs and many nonisotopic immunoassays use a competitive binding format (see Fig. 2). In this approach, the analyte in the sample to be measured competes with a known amount of added analyte that has been labeled with an indicator that binds to the immobilized antibody. After reaction, the free analyte—analyte-indicator solution is washed away from the soHd phase. The analyte-indicator on the soHd phase or remaining in the wash solution is then used to quantify the amount of analyte present in the sample as measured against a control assay using only an analyte-indicator. This is done by quantifying the analyte-indicator using the method appropriate for the assay, for example, enzyme activity, fluorescence, radioactivity, etc. 

For the determination of these compounds a binding inhibition immunoassay, consisting of the competitive immunoreaction of the unbound antibody present in an analyte-antibody mixture with the hapten derivative immobilized at the sensor surface, has been applied. With the aim of assuring the regeneration and reusability of the surface without denaturation of the immobilized molecule, the formation of an alkanethiol monolayer was carried out to provide covalent attachment of the ligand to the functionalized carbodiimide surface in a highly controlled way. For DDT, the assay sensitivity was evaluated in the 0.004 - 3545 pg/l range of pesticide concentration by the determination of the limit of detection 0.3 pg/1 and the I50 value 4.2 pg/1. 

---